Home/Filings/4/0001209191-18-057342
4//SEC Filing

MCAFEE LAWRANCE W 4

Accession 0001209191-18-057342

CIK 0000885978other

Filed

Nov 5, 7:00 PM ET

Accepted

Nov 6, 3:20 PM ET

Size

5.5 KB

Accession

0001209191-18-057342

Insider Transaction Report

Form 4
Period: 2018-11-02
MCAFEE LAWRANCE W
DirectorChief Financial Officer
Transactions
  • Sale

    Common Stock

    2018-11-02$113.29/sh3,100$351,19919,507 total
Footnotes (2)
  • [F1]The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $112.00 - $115.49, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
  • [F2]Includes 17,629 shares of restricted stock granted under the Company's equity plans. Restrictions lapse as to 3,102 shares on January 1, 2019; 1,852 shares on each of April 1, 2019, July 1, 2019, October 1, 2019 and January 1, 2020; and 1,142 shares on each of April 1, July 1 and October 1, 2020; 1,157 shares on January 1, 2021; 632 shares on each of April 1, July 1 and October 1, 2021; and 640 shares on January 1, 2022.

Issuer

U S PHYSICAL THERAPY INC /NV

CIK 0000885978

Entity typeother

Related Parties

1
  • filerCIK 0001263096

Filing Metadata

Form type
4
Filed
Nov 5, 7:00 PM ET
Accepted
Nov 6, 3:20 PM ET
Size
5.5 KB